Globant, an Argentina-based outsourced IT services provider, announced terms for its IPO on Monday. The company, which is based in Luxembourg but operates primarily out of Buenos Aires, Argentina, plans to raise $76 million by offering 6.3 million...read more
Deal flow picked up last week with ten IPOs pricing and raising almost $1.9 billion in proceeds. Though it was a strong week for pricings, six of the ten deals slashed...read more
Luxoft Holding, a spin-off of Russia-based IBS Group's offshore IT services business, raised $70 million by offering 4.1 million shares (50% insider) at $17, the midpoint of the range of $16 to $18. Luxoft plans to list on the NYSE under the symbol LXFT. Luxoft...read more
For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more
Argentinian IT services provider Globant sets terms for $76 million IPO
Globant, an Argentina-based outsourced IT services provider, announced terms for its IPO on Monday. The company, which is based in Luxembourg but operates primarily out of Buenos Aires, Argentina, plans to raise $76 million by offering 6.3 million...read more
US IPO Recap: Market picks up the pace with ten IPOs, six price below the range
Deal flow picked up last week with ten IPOs pricing and raising almost $1.9 billion in proceeds. Though it was a strong week for pricings, six of the ten deals slashed...read more
Luxoft prices IPO at $17 midpoint, raising $70 million
Luxoft Holding, a spin-off of Russia-based IBS Group's offshore IT services business, raised $70 million by offering 4.1 million shares (50% insider) at $17, the midpoint of the range of $16 to $18. Luxoft plans to list on the NYSE under the symbol LXFT. Luxoft...read more
US IPO Recap: Coty fades, Gigamon springs and 17 companies file or set terms
For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more